Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pyxis Discovery and its partner ZoBio have initiated a fragment based drug discovery project in collaboration with NewLink Genetics.
Subscribe to our email newsletter
The project includes the discovery of new drugs that target immunomodulatory pathways involved in cancer and infectious diseases.
In the project, ZoBio’s proprietary fragment screening technology, TINS, will be applied to screen a fragment library of Pyxis Discovery against multiple targets provided by NewLink Genetics, aiming to identify novel lead molecules.